Exploiting Botulinum Neurotoxins for the Study of Brain Physiology and Pathology
Botulinum neurotoxins are metalloproteases that specifically cleave N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins in synaptic terminals, resulting in a potent inhibition of vesicle fusion and transmitter release. The family comprises different serotypes (BoNT/A to Bo...
Main Authors: | Matteo Caleo, Laura Restani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-04-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/10/5/175 |
Similar Items
-
Recombinant botulinum neurotoxin serotype A1 in vivo characterization
by: Cindy Périer, et al.
Published: (2021-10-01) -
Engineering an Effective Human SNAP-23 Cleaving Botulinum Neurotoxin A Variant
by: Stefan Sikorra, et al.
Published: (2020-12-01) -
Botulinum Neurotoxin Serotypes Detected by Electrochemical Impedance Spectroscopy
by: Alison C. Savage, et al.
Published: (2015-05-01) -
Electrochemical impedance spectroscopy biosensor for detection of active botulinum neurotoxin
by: Jennifer Halliwell, et al.
Published: (2014-12-01) -
Nano-Organization at the Synapse: Segregation of Distinct Forms of Neurotransmission
by: Natalie J. Guzikowski, et al.
Published: (2021-12-01)